$HIMS
Hims & Hers Health, Inc. Stock $hims

$hims Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000177375124000025 Filed on February 26, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$246.6M	$872.0M	$167.2M
YoY Change	47.5%	65.49%	97.4%
Cost Of Revenue	$42.56M	$157.1M	$34.90M
YoY Change	21.95%	32.88%	54.42%
Gross Profit	$204.1M	$714.9M	$132.3M
YoY Change	54.24%	74.92%	113.05%
Gross Profit Margin	82.74%	81.99%	79.13%
Selling, General & Admin	$204.0M	$576.3M	$142.8M
YoY Change	42.82%	55.43%	72.52%
% of Gross Profit	99.95%	80.61%	107.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.658M	$9.515M	$2.010M
YoY Change	32.24%	27.31%	23.31%
% of Gross Profit	1.3%	1.33%	1.52%
Operating Expenses	$204.0M	$744.4M	$142.8M
YoY Change	42.82%	55.92%	72.52%
Operating Profit	$107.0K	-$29.45M	-$10.50M
YoY Change	-101.02%	-57.13%	-49.21%
Interest Expense	-$19.00K	-$1.075M	$500.0K
YoY Change	-103.8%	-139.81%	-105.15%
% of Operating Profit	-17.76%
Other Income/Expense, Net	$2.615M	$7.882M	$0.00
YoY Change		163.79%	-100.0%
Pretax Income	$2.196M	-$21.57M	-$11.00M
YoY Change	-119.96%	-67.17%	-64.8%
Income Tax	$951.0K	$1.975M	-$100.0K
% Of Pretax Income	43.31%
Net Earnings	$1.245M	-$23.50M	-$10.90M
YoY Change	-111.42%	-64.23%	-65.02%
Net Earnings / Revenue	0.5%	-2.69%	-6.52%
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	$0.01	-$0.11	-$0.05
COMMON SHARES
Basic Shares Outstanding		209.3M shares
Diluted Shares Outstanding		209.3M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$221.0M	$221.0M	$179.7M
YoY Change	22.98%	23.04%	-27.33%
Cash & Equivalents	$96.70M	$96.66M	$46.80M
Short-Term Investments	$124.3M	$124.3M	$132.9M
Other Short-Term Assets	$5.238M	$21.61M	$1.785M
YoY Change	193.45%	77.11%	100.56%
Inventory	$22.46M	$22.46M	$21.56M
Prepaid Expenses	$10.67M		$10.39M
Receivables	$6.700M	$5.705M	$3.900M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$265.1M	$265.1M	$216.6M
YoY Change	22.37%	22.37%	-19.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.73M	$45.73M	$3.000M
YoY Change	1424.37%	184.04%	36.36%
Goodwill	$110.9M		$110.9M
YoY Change	0.0%		0.0%
Intangibles	$18.57M		$21.84M
YoY Change	-14.96%		-15.64%
Long-Term Investments
YoY Change
Other Assets	$91.00K	$947.0K	$11.23M
YoY Change	-99.19%	5.22%	41.43%
Total Long-Term Assets	$176.1M	$176.1M	$149.7M
YoY Change	17.62%	17.66%	-0.62%
TOTAL ASSETS
Total Short-Term Assets	$265.1M	$265.1M	$216.6M
Total Long-Term Assets	$176.1M	$176.1M	$149.7M
Total Assets	$441.2M	$441.2M	$366.3M
YoY Change	20.43%	20.44%	-12.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$43.07M	$43.07M	$32.36M
YoY Change	33.08%	32.93%	64.78%
Accrued Expenses	$28.97M	$30.25M	$12.45M
YoY Change	132.74%	232.45%	2.08%
Deferred Revenue	$7.733M		$1.472M
YoY Change	425.34%		-53.83%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$88.47M	$88.47M	$47.94M
YoY Change	84.54%	84.69%	-39.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$22.00K	$8.689M	$35.00K
YoY Change	-37.14%	29.69%	-94.44%
Total Long-Term Liabilities	$22.00K	$8.689M	$35.00K
YoY Change	-37.14%	29.69%	-94.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.47M	$88.47M	$47.94M
Total Long-Term Liabilities	$22.00K	$8.689M	$35.00K
Total Liabilities	$97.16M	$97.16M	$54.60M
YoY Change	77.94%	77.94%	-36.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$368.2M		-$344.6M
YoY Change	6.85%		23.53%
Common Stock	$712.3M		$656.6M
YoY Change	8.48%		7.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$344.0M	$344.0M	$311.7M
YoY Change
Total Liabilities & Shareholders Equity	$441.2M	$441.2M	$366.3M
YoY Change	20.43%	20.44%	-12.9%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$1.245M	-$23.50M	-$10.90M
YoY Change	-111.42%	-64.23%	-65.02%
Depreciation, Depletion And Amortization	$2.658M	$9.515M	$2.010M
YoY Change	32.24%	27.31%	23.31%
Cash From Operating Activities	$21.98M	$73.50M	-$6.720M
YoY Change	-427.13%	-377.36%	116.43%
INVESTING ACTIVITIES
Capital Expenditures	$11.20M	$26.49M	$2.620M
YoY Change	327.4%	265.41%	-276.31%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$31.89M	$14.39M	$8.620M
YoY Change	269.99%	-65.71%	-26.5%
Cash From Investing Activities	$20.70M	-$12.11M	$6.000M
YoY Change	244.92%	-134.89%	-41.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.999M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.963M	-$11.48M	-10.46M
YoY Change	-62.11%	-65.36%	13310.26%
NET CHANGE
Cash From Operating Activities	21.98M	$73.50M	-6.720M
Cash From Investing Activities	20.70M	-$12.11M	6.000M
Cash From Financing Activities	-3.963M	-$11.48M	-10.46M
Net Change In Cash	38.72M	$49.89M	-11.18M
YoY Change	-446.29%	-299.47%	-258.38%
FREE CASH FLOW
Cash From Operating Activities	$21.98M	$73.50M	-$6.720M
Capital Expenditures	$11.20M	$26.49M	$2.620M
Free Cash Flow	$10.79M	$47.01M	-$9.340M
YoY Change	-215.47%	-239.28%	476.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	73483000	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	157239000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001773751
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	HIMS & HERS HEALTH, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity File Number EntityFileNumber	001-38986
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1482650
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2269 Chestnut Street, #523
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94123
CY2023	dei	City Area Code CityAreaCode	415
CY2023	dei	Local Phone Number LocalPhoneNumber	851-0195
CY2023	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	HIMS
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1800000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96663000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46772000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	124318000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	132853000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22464000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	21562000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21608000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15408000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	265053000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	216595000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	110881000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	110881000	usd
CY2023Q4	hims	Property Equipment And Software Net PropertyEquipmentAndSoftwareNet	36143000	usd
CY2022Q4	hims	Property Equipment And Software Net PropertyEquipmentAndSoftwareNet	11199000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18574000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21841000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9588000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4936000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	91000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33000	usd
CY2023Q4	us-gaap	Assets Assets	441186000	usd
CY2022Q4	us-gaap	Assets Assets	366341000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43070000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	32363000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28972000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12448000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7733000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1472000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	7412000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1281000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1658000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	88468000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47941000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8667000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3649000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2975000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	35000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	97157000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	54600000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	712307000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	656626000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-124000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-277000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368175000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-344629000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	344029000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	311741000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441186000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	366341000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	872000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	526916000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271878000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	157051000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	118194000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	67384000	usd
CY2023	us-gaap	Gross Profit GrossProfit	714949000	usd
CY2022	us-gaap	Gross Profit GrossProfit	408722000	usd
CY2021	us-gaap	Gross Profit GrossProfit	204494000	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	272587000	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	135902000	usd
CY2021	hims	Operations And Support Expense OperationsAndSupportExpense	47593000	usd
CY2023	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	1075000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8957000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2918000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7882000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2988000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4247000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21571000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-65709000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110795000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1975000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-23546000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65678000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	153000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-140000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-126000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23393000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65818000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107785000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	209344712	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	209344712	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	204516120	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	204516120	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	186781537	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	186781537	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-146874000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21902000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	249837000	usd
CY2021	hims	Adjustments To Additional Paid In Capital Related Party Receivable Repayment AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment	854000	usd
CY2021	hims	Adjustments To Additional Paid In Capital Warrant Conversion AdjustmentsToAdditionalPaidInCapitalWarrantConversion	1160000	usd
CY2021	hims	Stock Exercised During Period Value Common Stock Warrants StockExercisedDuringPeriodValueCommonStockWarrants	21679000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	18700000	usd
CY2021	hims	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	129659000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75000000	usd
CY2021	hims	Adjustments To Additional Paid In Capital Recapitalization Warrant Expense AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense	154000	usd
CY2021	hims	Stock Issued During Period Value Contingent Consideration Reverse Recapitalization StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization	1000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	52614000	usd
CY2021	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	227000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67767000	usd
CY2021	hims	Share Based Payment Arrangement Payment For Taxes Related To Net Share Settlement Of Equity Awards ShareBasedPaymentArrangementPaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	5998000	usd
CY2021	hims	Stock Issued During Period Value Warrant Redemption StockIssuedDuringPeriodValueWarrantRedemption	16967000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-126000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	334619000	usd
CY2022	hims	Share Based Payment Arrangement Payment For Taxes Related To Net Share Settlement Of Equity Awards ShareBasedPaymentArrangementPaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	3901000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2246000	usd
CY2022	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	197000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1178000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43220000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-140000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65678000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	311741000	usd
CY2023	hims	Share Based Payment Arrangement Payment For Taxes Related To Net Share Settlement Of Equity Awards ShareBasedPaymentArrangementPaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	14096000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2322000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2298000	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1999000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67156000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	153000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	344029000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-23546000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65678000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9515000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7474000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4075000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	66080000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	42817000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	67211000	usd
CY2023	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-1075000	usd
CY2022	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	70000	usd
CY2021	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	3802000	usd
CY2023	hims	Noncash Warrant Expense NoncashWarrantExpense	0	usd
CY2022	hims	Noncash Warrant Expense NoncashWarrantExpense	0	usd
CY2021	hims	Noncash Warrant Expense NoncashWarrantExpense	154000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	144000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	5686000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-146000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2166000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-594000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3388000	usd
CY2023	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	429000	usd
CY2022	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	1127000	usd
CY2021	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	0	usd
CY2023	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-1922000	usd
CY2022	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-1605000	usd
CY2021	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-1510000	usd
CY2023	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	2691000	usd
CY2022	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	837000	usd
CY2021	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	1182000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-195000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-540000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	902000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8004000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9628000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6395000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6335000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3200000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-17000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7324000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	12723000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9853000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	16524000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	909000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	197000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6261000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1716000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1412000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1933000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1605000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1521000	usd
CY2023	hims	Earn Out Payable EarnOutPayable	0	usd
CY2022	hims	Earn Out Payable EarnOutPayable	-10184000	usd
CY2021	hims	Earn Out Payable EarnOutPayable	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26531000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34412000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	187700000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	266633000	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	170051000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	194259000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	158375000	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1574000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	35846000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3465000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	9272000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	4533000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	4175000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	17220000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2714000	usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	832000	usd
CY2023	hims	Payments For Deferred Consideration For Acquisitions PaymentsForDeferredConsiderationForAcquisitions	0	usd
CY2022	hims	Payments For Deferred Consideration For Acquisitions PaymentsForDeferredConsiderationForAcquisitions	459000	usd
CY2021	hims	Payments For Deferred Consideration For Acquisitions PaymentsForDeferredConsiderationForAcquisitions	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-156268000	usd
CY2023	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	usd
CY2022	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	usd
CY2021	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	22027000	usd
CY2023	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	0	usd
CY2022	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	0	usd
CY2021	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	197686000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	75000000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12851000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1193000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	787000	usd
CY2023	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	2322000	usd
CY2022	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	2246000	usd
CY2021	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	1253000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14096000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3901000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5998000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	32650000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2298000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1178000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1999000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11475000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33127000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	235043000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-53000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-73000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49891000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25012000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44290000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47628000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28350000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97519000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47628000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96663000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46772000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71784000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97519000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47628000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1109000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	636000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	338000	usd
CY2023	us-gaap	Recapitalization Costs RecapitalizationCosts	0	usd
CY2022	us-gaap	Recapitalization Costs RecapitalizationCosts	0	usd
CY2021	us-gaap	Recapitalization Costs RecapitalizationCosts	125000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	249837000	usd
CY2023	hims	Warrants Assumed WarrantsAssumed	0	usd
CY2022	hims	Warrants Assumed WarrantsAssumed	0	usd
CY2021	hims	Warrants Assumed WarrantsAssumed	51814000	usd
CY2023	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	0	usd
CY2022	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	0	usd
CY2021	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	37834000	usd
CY2023	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	0	usd
CY2022	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	0	usd
CY2021	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	1160000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3383000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6270000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1206000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	0	usd
CY2022	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	197000	usd
CY2021	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	227000	usd
CY2023	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	0	usd
CY2022	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	0	usd
CY2021	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	99958000	usd
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant estimates, judgments, and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation of contingent consideration in business combinations, purchase price allocation for business combinations, estimates used in the capitalization of website and mobile application development and internal-use software costs, and judgments relating to impairment triggering events for long-lived assets. Management believes that the estimates, judgments, and assumptions upon which it relies are reasonable based upon information available to it at the time that these estimates, judgments, and assumptions were made. Actual results experienced by the Company may differ from management’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s consolidated financial statements will be affected.</span></div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are potentially exposed to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, investments, and accounts receivable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash, cash equivalents, short-term investments, and restricted cash with high-quality financial institutions with investment-grade ratings. The majority of the cash balances are with U.S. banks and are insured to the extent defined by the Federal Deposit Insurance Corporation.</span></div>The prescription products ordered on the Company’s e-commerce online platform are primarily fulfilled by the Affiliated and Partner Pharmacies (as defined below). If any of the pharmacies were to stop fulfilling orders, it could significantly slow prescription product sales until fulfillment volume is redistributed to other operating pharmacies. The Company maintains agreements with these pharmacies and is continuing to invest in expanding affiliated pharmacy fulfillment capabilities to mitigate any such risk
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6700000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3900000	usd
CY2023Q4	hims	Capitalized Computer Software Expected Amortization Year One CapitalizedComputerSoftwareExpectedAmortizationYearOne	6461000	usd
CY2023Q4	hims	Capitalized Computer Software Expected Amortization Year Two CapitalizedComputerSoftwareExpectedAmortizationYearTwo	5058000	usd
CY2023Q4	hims	Capitalized Computer Software Expected Amortization Year Three CapitalizedComputerSoftwareExpectedAmortizationYearThree	2568000	usd
CY2023Q4	hims	Capitalized Computer Software Expected Amortization CapitalizedComputerSoftwareExpectedAmortization	14087000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	110900000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	400000	usd
CY2022	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	1100000	usd
CY2021	hims	Impairment Of Long Lived Assets Excluding Goodwill ImpairmentOfLongLivedAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	872000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	526916000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271878000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	3000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2000000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1200000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	usd
CY2023	hims	Customer Acquisition Costs CustomerAcquisitionCosts	390300000	usd
CY2022	hims	Customer Acquisition Costs CustomerAcquisitionCosts	235600000	usd
CY2021	hims	Customer Acquisition Costs CustomerAcquisitionCosts	103500000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-23500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	73500000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368200000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96700000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	124300000	usd
CY2021Q1	hims	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q1	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	197700000	usd
CY2021Q1	hims	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	18700000	usd
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Shares ReverseRecapitalizationContingentConsiderationEquityShares	16000000	shares
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne	15.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo	17.50
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree	20.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays	P10D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Day Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod	P20D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	2	acquisition
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	124290000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	43000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	15000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	124318000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	132989000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	153000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	132853000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15221000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16477000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	7243000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5085000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22464000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	21562000	usd
CY2023Q4	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	5705000	usd
CY2022Q4	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	3231000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10665000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10392000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5238000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1785000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21608000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15408000	usd
CY2023Q4	hims	Property Equipment And Software Gross PropertyEquipmentAndSoftwareGross	48387000	usd
CY2022Q4	hims	Property Equipment And Software Gross PropertyEquipmentAndSoftwareGross	17440000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12244000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6241000	usd
CY2023Q4	hims	Property Equipment And Software Net PropertyEquipmentAndSoftwareNet	36143000	usd
CY2022Q4	hims	Property Equipment And Software Net PropertyEquipmentAndSoftwareNet	11199000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	400000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	400000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	hims	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	impairment expense
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28973000	usd
CY2023Q4	hims	Finite Lived Intangible Assets Accumulated Amortization And Impairment FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment	10399000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18574000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28751000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6910000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21841000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	700000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2611000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2472000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1500000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2353000	usd
CY2023Q4	hims	Finite Lived Intangible Asset Expected Amortization Year Five And Thereafter FiniteLivedIntangibleAssetExpectedAmortizationYearFiveAndThereafter	8338000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18574000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	12331000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4990000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7888000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4999000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5341000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	643000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2009000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	963000	usd
CY2023Q4	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	562000	usd
CY2022Q4	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	263000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	841000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	590000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28972000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12448000	usd
CY2023	hims	Operating Lease Liability Remeasurement Adjustment OperatingLeaseLiabilityRemeasurementAdjustment	5700000	usd
CY2023	hims	Operating Lease Right Of Use Asset Remeasurement Adjustment OperatingLeaseRightOfUseAssetRemeasurementAdjustment	5700000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2400000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1900000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1800000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	400000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	300000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	300000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1900000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2114000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2207000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2219000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1955000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1696000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2827000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13018000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3070000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9948000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	7300000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	4800000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	2400000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	100000	usd
CY2023Q4	hims	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	commonstockclass
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.09
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.44
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6200000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6300000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12600000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	13784000	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	9688000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	14450000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	8389000	shares
CY2023	hims	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	12900000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	66080000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42817000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67211000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1700000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	600000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-16749000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-62539000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-109393000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4822000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3170000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1402000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21571000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-65709000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110795000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1747000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3897000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2018000	usd
CY2023	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants And Earnouts Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAndEarnoutsAmount	226000	usd
CY2022	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants And Earnouts Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAndEarnoutsAmount	-15000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	532000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1456000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	563000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	252000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1988000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	563000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	252000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-339000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2280000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-25000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-110000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-966000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-145000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-142000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-594000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3388000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1975000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4530000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-13799000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23267000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1636000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-609000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3498000	usd
CY2023	hims	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0	usd
CY2022	hims	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	-731000	usd
CY2021	hims	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	369000	usd
CY2021	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants And Earnouts Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAndEarnoutsAmount	-1710000	usd
CY2023	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	6386000	usd
CY2022	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	2881000	usd
CY2021	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	8352000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1330000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7794000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15971000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5398000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	714000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	613000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-136000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-62000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1371000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1975000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	53309000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	67214000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3779000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	15106000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2164000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1952000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3572000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4079000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1890000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2338000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	350000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	487000	usd
CY2023Q4	hims	Deferred Tax Assets Contract With Customer Liability DeferredTaxAssetsContractWithCustomerLiability	124000	usd
CY2022Q4	hims	Deferred Tax Assets Contract With Customer Liability DeferredTaxAssetsContractWithCustomerLiability	17000	usd
CY2023Q4	hims	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	2615000	usd
CY2022Q4	hims	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	1382000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	87000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	553000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	82996000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	78022000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70506000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	69357000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12490000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8665000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4777000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	5623000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1532000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1722000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1825000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2519000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1285000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1859000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	70000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12512000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8700000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	22000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	35000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1100000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	8000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	186100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	154800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	10800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	6100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1357000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	956000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2313000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, CA
CY2023	dei	Auditor Firm AuditorFirmId	185

Files In Submission

Name	View Source	Status
0001773751-24-000025-index-headers.html	Edgar Link	pending
0001773751-24-000025-index.html	Edgar Link	pending
0001773751-24-000025.txt	Edgar Link	pending
0001773751-24-000025-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hims-20231231.htm	Edgar Link	pending
hims-20231231.xsd	Edgar Link	pending
hims-20231231x10kxex311.htm	Edgar Link	pending
hims-20231231x10kxex312.htm	Edgar Link	pending
hims-20231231x10kxex321.htm	Edgar Link	pending
hims-20231231x10kxex322.htm	Edgar Link	pending
hims-20231231x10kxexhibit23.htm	Edgar Link	pending
hims-20231231xxex97policyr.htm	Edgar Link	pending
hims-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
hims-20231231_cal.xml	Edgar Link	unprocessable
hims-20231231_def.xml	Edgar Link	unprocessable
hims-20231231_pre.xml	Edgar Link	unprocessable
hims-20231231_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hims-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HIMS
Hims & Hers Health, Inc. Stock $hims

2023 Q4 Form 10-K Financial Statement

#000177375124000025 Filed on February 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS Hims & Hers Health, Inc. Stock $hims

2023 Q4 Form 10-K Financial Statement

#000177375124000025 Filed on February 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS
Hims & Hers Health, Inc. Stock $hims